These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28682528)

  • 1. S-Adenosylmethionine (SAMe) for Neuropsychiatric Disorders: A Clinician-Oriented Review of Research.
    Sharma A; Gerbarg P; Bottiglieri T; Massoumi L; Carpenter LL; Lavretsky H; Muskin PR; Brown RP; Mischoulon D;
    J Clin Psychiatry; 2017 Jun; 78(6):e656-e667. PubMed ID: 28682528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence to Support the Use of S-Adenosylmethionine for Treatment of Post-Concussive Sequelae in the Military.
    Schieffler DA; Matta SE
    Mil Med; 2022 Aug; 187(9-10):e1182-e1192. PubMed ID: 33900393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosyl methionine (SAMe) for depression in adults.
    Galizia I; Oldani L; Macritchie K; Amari E; Dougall D; Jones TN; Lam RW; Massei GJ; Yatham LN; Young AH
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011286. PubMed ID: 27727432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial.
    Green T; Steingart L; Frisch A; Zarchi O; Weizman A; Gothelf D
    J Neural Transm (Vienna); 2012 Nov; 119(11):1417-23. PubMed ID: 22678699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [S-adenosyl L-methionine in CNS diseases].
    Krzystanek M; Pałasz A; Krzystanek E; Krupka-Matuszczyk I; Wiaderkiewicz R; Skowronek R
    Psychiatr Pol; 2011; 45(6):923-31. PubMed ID: 22335134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropharmacology of S-adenosyl methionine.
    Carney MW
    Clin Neuropharmacol; 1986; 9(3):235-43. PubMed ID: 2424592
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of the dietary supplement S-adenosyl-L-methionine.
    Fetrow CW; Avila JR
    Ann Pharmacother; 2001 Nov; 35(11):1414-25. PubMed ID: 11724095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deployment of personnel to military operations: impact on mental health and social functioning.
    Bøg M; Filges T; Jørgensen AMK
    Campbell Syst Rev; 2018; 14(1):1-127. PubMed ID: 37131363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.
    De Berardis D; Orsolini L; Serroni N; Girinelli G; Iasevoli F; Tomasetti C; de Bartolomeis A; Mazza M; Valchera A; Fornaro M; Perna G; Piersanti M; Di Nicola M; Cavuto M; Martinotti G; Di Giannantonio M
    CNS Neurol Disord Drug Targets; 2016; 15(1):35-44. PubMed ID: 26295824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-Adenosyl-L-methionine (SAMe): from the bench to the bedside--molecular basis of a pleiotrophic molecule.
    Bottiglieri T
    Am J Clin Nutr; 2002 Nov; 76(5):1151S-7S. PubMed ID: 12418493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-adenosyl-methionine in depression: a comprehensive review of the literature.
    Papakostas GI; Alpert JE; Fava M
    Curr Psychiatry Rep; 2003 Dec; 5(6):460-6. PubMed ID: 14609501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
    Sarris J; Ravindran A; Yatham LN; Marx W; Rucklidge JJ; McIntyre RS; Akhondzadeh S; Benedetti F; Caneo C; Cramer H; Cribb L; de Manincor M; Dean O; Deslandes AC; Freeman MP; Gangadhar B; Harvey BH; Kasper S; Lake J; Lopresti A; Lu L; Metri NJ; Mischoulon D; Ng CH; Nishi D; Rahimi R; Seedat S; Sinclair J; Su KP; Zhang ZJ; Berk M
    World J Biol Psychiatry; 2022 Jul; 23(6):424-455. PubMed ID: 35311615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-adenosyl-l-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations.
    Taylor Levine M; Gao J; Satyanarayanan SK; Berman S; Rogers JT; Mischoulon D
    Brain Behav Immun; 2020 Mar; 85():152-161. PubMed ID: 31301401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. St. John's wort and S-adenosyl methionine as "natural" alternatives to conventional antidepressants in the era of the suicidality boxed warning: what is the evidence for clinically relevant benefit?
    Carpenter DJ
    Altern Med Rev; 2011 Mar; 16(1):17-39. PubMed ID: 21438644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002235. PubMed ID: 11687153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic indications of S-adenosyl methionine in neuropsychiatry].
    Tramoni AV; Azorin JM
    Encephale; 1988; 14(3):113-8. PubMed ID: 2900133
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.